HealthDay Reporter
THURSDAY, Aug. 11, 2022 (HealthDay Information) — The USA has an opioid epidemic, however there’s one vibrant spot within the battle in opposition to it: Prescriptions for these addictive medication have declined for sufferers with non-public insurance coverage.
Amid pointers over the previous decade from governments, well being programs and insurers geared toward decreasing opioid prescriptions, earlier research have pointed to a nationwide drop in prescribing charges.
Sufferers who’re actively receiving most cancers therapies are excluded from these limits.
The brand new examine included most cancers sufferers in addition to folks with different chronic pain. It discovered that general prescribing charges nonetheless dropped.
“We discover that from 2012 to 2019 there have been declines in opioid prescribing for people with power non-cancer ache and people with most cancers with out corresponding will increase in receipt of non-opioid therapies,” authors Sachini Bandara and Emma McGinty of Johns Hopkins Bloomberg College of Public Well being in Baltimore, and Dr. Mark Bicket of the College of Michigan, wrote.
The examine was revealed Aug. 10 in PLOS ONE .
“These findings spotlight the necessity to higher perceive how declines in prescribing are influencing the administration of ache amongst these affected person populations, significantly because the [U.S. Centers for Disease Control and Prevention] is at present updating opioid prescribing pointers for power ache,” the authors mentioned in a journal information launch.
For the examine, the researchers analyzed insurance coverage claims from 100 non-public firms. They checked out sufferers with most cancers and people with different types of pain, together with low back pain, neuropathic pain, complications or arthritis.
Between 2012 and 2019, the proportion of people that had been prescribed an opioid for cancer-related ache dropped from 86% to 78.7%, the examine discovered. Those that obtained opioid prescriptions for different forms of ache dropped from 49.7% to 30.5%.
Whereas charges of non-opioid ache treatment had been regular for folks with non-cancer ache, researchers discovered they rose for most cancers sufferers from 74.4% to 78.8%.
For individuals who nonetheless obtained opioids, fewer folks obtained extraordinarily excessive doses or greater than a one-week provide, the researchers reported.
They mentioned extra examine is required to find out how the revised pointers influenced ache administration in each teams.
Extra info
The U.S. Division of Well being and Human Companies has extra on the opioid epidemic.
SOURCE: PLOS ONE, information launch, Aug. 10, 2022
